Why choose PULS?
23 February, 2017
PULS is a Swedish life science company with a unique combination of scientists and industrialists who together with innovators are commercializing ideas by providing capital, know-how and committed partnership.
PULS is an attractive alternative for researchers who would like to commercialize an idea without having to start companies, become entrepreneurs, or take the risks and do all the work required to succeed.
PULS is a small and cost-efficient organization, with a lean decision-making process that manages its projects in close collaboration with the innovators.
PULS has a proven track record. For example, PULS has succeeded in getting a medication approved within the EU and successfully sold two portfolio companies, including DuoCort – a deal valued at 1 billion SEK.